Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ezh2-Interacting Lncrnas Contribute to Gastric Tumorigenesis; a Review on the Mechanisms of Action Publisher Pubmed



Mohebbi H1 ; Esbati R2 ; Hamid RA3 ; Akhavanfar R4 ; Radi UK5 ; Siri G6 ; Yazdani O2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Kermanshah University of medical sciences, International branch, Kermanshah, Iran
  2. 2. Department of Medicine, Shahid Beheshti University, Tehran, Iran
  3. 3. Department of Pharmacy, Al-Noor University College, Nineveh, Iraq
  4. 4. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. College of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq
  6. 6. Department of Internal Medicine, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Molecular Biology Reports Published:2024


Abstract

Gastric cancer (GC) remains one of the deadliest malignancies worldwide, demanding new targets to improve its diagnosis and treatment. Long non-coding RNAs (lncRNAs) are dysregulated through gastric tumorigenesis and play a significant role in GC progression and development. Recent studies have revealed that lncRNAs can interact with histone-modifying polycomb protein, enhance Zeste Homolog 2 (EZH2), and mediate its site-specific functioning. EZH2, which functions as an oncogene in GC, is the catalytic subunit of the PRC2 complex that induces H3K27 trimethylation and epigenetically represses gene expression. EZH2-interacting lncRNAs can recruit EZH2 to the promoter regions of various tumor suppressor genes and cause their transcriptional deactivation via histone methylation. The interactions between EZH2 and this lncRNA modulate different processes, such as cell cycle, cell proliferation and growth, migration, invasion, metastasis, and drug resistance, in vitro and in vivo GC models. Therefore, EZH2-interacting lncRNAs are exciting targets for developing novel targeted therapies for GC. Subsequently, this review aims to focus on the roles of these interactions in GC progression to understand the therapeutic value of EZH2-interacting lncRNAs further. © The Author(s), under exclusive licence to Springer Nature B.V. 2024.
Related Docs
View other Related Docs
1. A Comprehensive Review of the Role of Lncrnas in Gastric Cancer (Gc) Pathogenesis, Immune Regulation, and Their Clinical Applications, Pathology Research and Practice (2023)
2. A Comprehensive Insight Into the Correlation Between Ncrnas and the Wnt/Β-Catenin Signalling Pathway in Gastric Cancer Pathogenesis, Cell Communication and Signaling (2023)
3. Long Non-Coding Rnas As Potential Biomarkers or Therapeutic Targets in Gastric Cancer, Gastroenterology and Hepatology from Bed to Bench (2023)
4. Comprehensive Analysis of Ernas and Genes Involved in Gastric Cancer and Constructing a Prognostic Model Predicting the Overall Survival of Patients, Journal of Isfahan Medical School (2023)
5. Comprehensive Competitive Endogenous Rna Network Analysis Reveals Ezh2-Related Axes and Prognostic Biomarkers in Hepatocellular Carcinoma, Iranian Journal of Basic Medical Sciences (2022)
6. Knockdown of Long Noncoding Rna Plasmacytoma Variant Translocation 1 With Antisense Locked Nucleic Acid Gapmers Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of C-Myc Expression, Cancer Biotherapy and Radiopharmaceuticals (2019)
7. New Long Noncoding Rna Biomarkers and Cerna Networks on Mir‑616‑3P in Colorectal Cancer: Bioinformatics‑Based Study, Journal of Research in Medical Sciences (2024)
8. New Insights Into the Long Non-Coding Rnas Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment, Current Medicinal Chemistry (2024)
Experts (# of related papers)
View all Related Experts
Mohammadreza Sharifi (9)
Parvaneh Nikpour (8)
Other Related Docs
9. Effects of Hsa-Pir-32877 Suppression With Antisense Lna Gapmers on the Proliferation and Apoptosis of Human Acute Myeloid Leukemia Cells, International Journal of Molecular and Cellular Medicine (2023)
10. Circulating Micrornas As Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives, Current Medicinal Chemistry (2016)
11. H19: A Regulatory Biomarker With Prognostic Value in Leukemias, Eurasian Journal of Medicine and Oncology (2019)
12. Msi2 Expression Is Decreased in Grade Ii of Gastric Carcinoma, Pathology Research and Practice (2013)
13. Constructing a Novel Competing Endogenous Rnas Network Based on Nr3c1 and X-Linked Inhibitor of Apoptosis Protein Genes Reveals Potential Prognostic Biomarkers in Colorectal Cancer, Journal of Research in Medical Sciences (2022)
14. A Spotlight on the Interplay Between Wnt/Β-Catenin Signaling and Circular Rnas in Hepatocellular Carcinoma Progression, Frontiers in Oncology (2023)
15. Differential Expression and Pathological Implications of Linc01089 and Linc01578 in Acute Myeloid Leukemia, Gene Reports (2025)
16. Long Noncoding Rnas in Gastric Cancer Carcinogenesis and Metastasis, Briefings in Functional Genomics (2017)
17. The Prominent Role of Mir-942 in Carcinogenesis of Tumors, Advanced Biomedical Research (2022)
18. Tribbles Homolog 2 (Trib2), a Pseudo Serine/Threonine Kinase in Tumorigenesis and Stem Cell Fate Decisions, Cell Communication and Signaling (2021)
19. Epigenetic Regulation in Myocardial Infarction: Non-Coding Rnas and Exosomal Non-Coding Rnas, Frontiers in Cardiovascular Medicine (2022)
20. Augmented Expression Levels of Lncrnas Eccebpa and Uca1 in Gastric Cancer Tissues and Their Clinical Significance, Iranian Journal of Basic Medical Sciences (2017)
21. Modulation of Long Non-Coding Rnas and Micrornas by Quercetin As a Potential Therapeutical Approach in Cancer: A Comprehensive Review, Current medicinal chemistry (2025)
22. Multiple Function of Lncrna Malat1 in Cancer Occurrence and Progression, Chemical Biology and Drug Design (2023)
23. Emerging Roles for Lncrna-Neat1 in Colorectal Cancer, Cancer Cell International (2022)
24. Circular Rnas-Mediated Angiogenesis in Human Cancers, Clinical and Translational Oncology (2023)
25. Dysregulated of the Fam138e and Clrn1-As1 Lncrnas Could Be Diagnosis Biomarkers in Colorectal Cancer, Human Gene (2024)
26. Lncarod Promotes the Proliferation and Migration of Gastric Cancer: A Bioinformatics Analysis and Experimental Validation, Functional and Integrative Genomics (2023)
27. Lncrna Flvcr1-As1 Sponges Mir-381-3P and Promotes Wnt Signaling Pathway Resulting in Colorectal Cancer Progression, Egyptian Journal of Medical Human Genetics (2025)
28. System Biology Analysis to Develop Diagnostic Biomarkers, Monitoring Pathological Indexes, and Novel Therapeutic Approaches for Immune Targeting Based on Maggot Bioactive Compounds and Polyphenolic Cocktails in Mice With Gastric Cancer, Environmental Research (2023)
29. Aberrant Expression of Plncrna-1 and Tug1: Potential Biomarkers for Gastric Cancer Diagnosis and Clinically Monitoring Cancer Progression, Biomarkers in Medicine (2017)
30. Emerging Roles of Jmjd3 in Cancer, Clinical and Translational Oncology (2022)
31. The Effect of Long Non-Coding Rna Pvt1 Inhibition by Antisense Lna Gapmers Technology on Proliferation of Human Acute Erythroleukemia Cells, Journal of Isfahan Medical School (2018)
32. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)
33. Lna Inhibitor in Microrna Mir-23B As a Potential Anti-Proliferative Option in Human Hepatocellular Carcinoma, Journal of Gastrointestinal Cancer (2020)
34. Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression, Biomedicine and Pharmacotherapy (2017)
35. Reduce Proliferation of Human Bone Marrow Cells From Acute Myeloblastic Leukemia With Minimally Differentiation by Blocking Lncrna Pvt1, Clinical and Translational Oncology (2020)
36. Inhibition of Microrna Mir-92A Induces Apoptosis and Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia Through Modulation of P63 Expression, Molecular Biology Reports (2014)
37. Microrna in Leukemia: Tumor Suppressors and Oncogenes With Prognostic Potential, Journal of Cellular Physiology (2019)
38. Non-Coding Rnas in Leukemia Drug Resistance: New Perspectives on Molecular Mechanisms and Signaling Pathways, Annals of Hematology (2024)
39. Exploring Potential Roles of Long Non-Coding Rnas in Cancer Immunotherapy: A Comprehensive Review, Frontiers in Immunology (2024)
40. Microrna-30C-2-3P Regulates Er Stress and Induces Apoptosis in Ovarian Cancer Cells Underlying Er Stress, EXCLI Journal (2021)
41. Epigenetic Regulation of Autophagy in Gastrointestinal Cancers, Biochimica et Biophysica Acta - Molecular Basis of Disease (2022)
42. Induction of Apoptosis and Necrosis in Human Acute Erythroleukemia Cells by Inhibition of 47Tlong Non-Coding Rna Pvt1, Molecular Biology Research Communications (2018)
43. Construction of a Cell Cycle-Specific Lncrna-Mirna-Mrna Network Reveals Novel Key Lncrnas in Colorectal Cancer, Biomarkers (2024)
44. Potential Roles of Lncrna-Xist/Mirnas/Mrnas in Human Cancer Cells, Clinical and Translational Oncology (2023)
45. Integrated Analysis of Transcriptome and Epigenome Reveals Ensr00000272060 As a Potential Biomarker in Gastric Cancer, Epigenomics (2024)
46. The Pathogenic Roles of Lncrna-Taurine Upregulated 1 (Tug1) in Colorectal Cancer, Cancer Cell International (2022)
47. Epi-Drugs and Epi-Mirs: Moving Beyond Current Cancer Therapies, Current Cancer Drug Targets (2016)